Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2003
10/16/2003WO2003084977A1 Gene expression control system and its use in recombinant virus packaging cell lines
10/16/2003WO2003084566A2 Proteins involved in the regulation of energy homeostasis
10/16/2003WO2003084560A2 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
10/16/2003WO2003084540A2 Compositions comprising mmp7 modulators for the treatment of chronic pain
10/16/2003WO2003084508A1 Delivery of a substance to a pre-determined site
10/16/2003WO2003084479A2 Large scale methods of producing adenovirus and adenovirus seed stocks
10/16/2003WO2003084470A2 Compositions and methods for targeted biological delivery of molecular carriers
10/16/2003WO2003068954A3 Microorganism for genetic therapeutic treatment of proliferative diseases
10/16/2003WO2003068809A3 An herpes simplex virus complex
10/16/2003WO2003062276A3 Multimers of receptor-binding ligands
10/16/2003WO2003057729A3 Mammal prolactin variants
10/16/2003WO2003045335A3 Stem cell screening and transplantation therapy for hiv infection
10/16/2003WO2003042368A3 Methods of expressing lim mineralization protein in non-osseous cells
10/16/2003WO2003039575A3 Use of reelin, gas6, and protein s in the treatment of neural disorders
10/16/2003WO2003029434A3 Novel molecules of the hkid-1-related protein family and uses thereof
10/16/2003WO2003029413A3 A novel g protein-coupled receptor, gave 10
10/16/2003WO2003028634A3 Method of treatment using ligand-immunogen conjugates
10/16/2003WO2003026492A3 Prevention and treatment of restenosis by local administration of drug
10/16/2003WO2003014359A3 A fusion protein
10/16/2003WO2003010192A3 An inducer of apoptosis
10/16/2003WO2003008586A3 Engineering oncolytic viruses
10/16/2003WO2003004704A3 Method of selecting dna sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
10/16/2003WO2003004520A3 Mycobacterial antigens expressed during latency
10/16/2003WO2002102840A3 Multiners of class i major histocompatibility complexes cantaining modified beta2-microglobulin proteins
10/16/2003WO2002099043A3 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
10/16/2003WO2002098899A3 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
10/16/2003WO2002097043A3 Wnv core protein/capsid interacting protein and uses of the same
10/16/2003WO2002064838A3 Amplified cancer gene wip1
10/16/2003WO2002061104A3 Hybrid adenoviral vector
10/16/2003WO2002060930A3 Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith
10/16/2003WO2002044384A3 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
10/16/2003WO2002032954A3 Phosphorylation modifications of apoptin
10/16/2003WO2002029074A3 Genetic immunisation against cervical carcinoma
10/16/2003US20030196212 An isolated nucleic acid sequence encoding a polypeptide specific bind to the receptor; treating infertility, contraception disorders, sexual dysfunction, nervous system disorders, psychiatric disorders, liver disorders
10/16/2003US20030195349 H. pylori flbA polypeptides, immunogenic and vaccinating compositions comprising H. pylori flbA polypeptides, and compositions for detection of an infection comprising H. pylori flbA polypeptides
10/16/2003US20030195333 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195168 Comprises macrocyclic diterpene compounds from Euphorbiaceae for treatment and prophylaxis of protein kinase C (PKC) related conditions (alcoholism, Alzheimer's disease, asthma, atherosclerosis); expression inhibition; computer programs
10/16/2003US20030195162 Genetic marker for spondyloepimetaphyseal dysplasia
10/16/2003US20030195148 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195147 Identification of molecular structures, especially peptides, which are capable of acting at either insulin or insulin-like growth factor receptors as agonists or antagonists; treatment of diabetes
10/16/2003US20030194800 For immunization, generation of packaging cell lines, and production of immunogenic compositions
10/16/2003US20030194761 Novel nucleic acid sequences encoding human fibroblast growth factor-like polypeptides
10/16/2003US20030194725 Creating a database of related protein/nucleic acid sequences with annotations of the potential disease associations of the sequences; testing the potential disease associations by means of a biological assay and validating the disease association
10/16/2003US20030194720 Human ion channels
10/16/2003US20030194694 Pure recombinant influenza virus comprising a mutant ion channel protein which lacks or has reduced activity relative to the wild-type
10/16/2003US20030194406 P-cadherin as a target for anti-cancer therapy
10/16/2003US20030194396 Antisense oligonucleotide that hybridizes iwth and inhibits the expression of human pituitary tumor-transforming gene
10/16/2003US20030194393 Toxoplasma gondii proteins, nucleic acid molecules, and uses thereof
10/16/2003US20030194392 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
10/16/2003US20030194391 Vaccine
10/16/2003US20030192555 Direct arterial infiltration for production of vascular pathology
10/16/2003CA2513149A1 A human ribonucleotide reductase m2 subunit
10/16/2003CA2481090A1 Novel pancortin-pablo protein interactions and methods of use thereof
10/16/2003CA2480311A1 Oligomeric compounds for the modulation of hif-1alpha expression
10/16/2003CA2480084A1 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
10/16/2003CA2478932A1 Large scale methods of producing adenovirus and adenovirus seed stocks
10/16/2003CA2477298A1 Use of biomolecular targets in the treatment and visualization of brain tumors
10/15/2003EP1352960A1 Antiviral therapy on the basis of RNA interference
10/15/2003EP1352956A1 Inhibition of DNA methyltransferase
10/15/2003EP1352092A2 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
10/15/2003EP1352088A2 Genes comprising coding mononucleotide microsatellites or dinucleotide microsatellites that can be isolated from tumor cells
10/15/2003EP1352084A2 Method for identifying modulators of bace
10/15/2003EP1352078A1 Selectable marker for genetically engineered cells and tissues
10/15/2003EP1352073A2 Electrically responsive promoter system
10/15/2003EP1352072A2 Nucleic acid delivery formulations
10/15/2003EP1352071A1 Vector for introducing molecules in eukaryotic cells and molecules vectorized by same
10/15/2003EP1352063A2 Receptor nucleic acids and polypeptides
10/15/2003EP1352061A2 Method for inhibiting the expression of a target gene
10/15/2003EP1352056A2 Polypeptides
10/15/2003EP1351986A2 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii
10/15/2003EP1351985A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
10/15/2003EP1351978A2 Retrovirus isolated from humans
10/15/2003EP1351972A1 Lipids comprising an aminoxy group
10/15/2003EP1351968A1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
10/15/2003EP1351744A2 Erbb4 antagonists
10/15/2003EP1351711A2 Generation and/or reduction of new lung tissue in an affected lung, by modulation of the wnt-pathway
10/15/2003EP1351710A2 Compositions containing inclusion complexes
10/15/2003EP1351702A1 Trem-1 splice variant for use in modifying immune responses
10/15/2003EP1351648A2 Carrier vectors through an epithelium with tight junctions
10/15/2003EP1079864B1 Entomopoxvirus vector for delivery and expression of heterologous dna in vertebrate cells
10/15/2003EP0975370B1 Composition and method for enhancing transport across biological membranes
10/15/2003EP0796276B1 Gradual modification, super-agonists and antagonists of signal-proteins and peptides
10/15/2003EP0716591B1 USE OF ApoE FOR BINDING TAU AND MAP2c PROTEINS AND FOR TREATING ALZHEIMER'S DISEASE
10/15/2003EP0706568B1 Vertebrate apoptosis gene: compositions and methods
10/15/2003CN1449448A 干细胞分化 Stem cell differentiation
10/15/2003CN1449445A Ev-vegf nucleic acids and polypeptides and methods of use
10/15/2003CN1449440A Masp-2, a complement-fixing enzyme, and uses for it
10/15/2003CN1449410A Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
10/15/2003CN1448183A Tumour-curing specific target guiding administration system and use in preparation of tumour-curing medicine
10/15/2003CN1124348C Multi-functional hematopoietic receptor agonists
10/14/2003US6632936 Anticancer agents
10/14/2003US6632923 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
10/14/2003US6632920 Immunology; diagnosing cancer, nervous system, brain, sleep, psychological, and disorders
10/14/2003US6632790 Recombinant DNA produced; pathogen free; high purity
10/14/2003US6632672 Site-specifically integrating a polynucleotide sequence of interest in a genome of a eucaryotic cell, as well as, enzymes, polypeptides and variety of vector constructs for the generation of transgenic cells, tissues, plants, and animals
10/14/2003US6632670 Recombinant adeno-associated virus (AAV) with reduced levels of helper virus; cells which have been transfected with plasmid comprising nucleotide sequences encoding replication (rep) and capsid (cap) proteins
10/14/2003US6632647 Use of strains of parapoxvirus ovis against organ fibrosis
10/14/2003US6632628 Use to detect compounds having therapeutic activity toward cardiac hypertrophy
10/14/2003US6632627 DNA coding for the protein; useful for a prophylactic or therapeutic agent for hypoglycemia.
10/14/2003US6632430 Administering enzyme inhibitors of S-adenosyl methionine synthetase (SAMS), of S-adenosyl homocysteine hydrolase (SAHH) and of transmethylases, RNA transmethylase and DNA transmethylase; antidotes; detoxification
1 ... 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 ... 870